Filters Applied:
Normal language is inadequate and precedents are irrelevant when it comes to appraising the senior administration officials of the president’s second term.
| Keywords | trumppoliticsrepublicanscabinetadministrationus-governmentpresidencynational-securitytechconservativeopinionnytimesfrank-brunibret-stephenslawgovernmentpolicywashington-dcpoliticswhite-house |
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent.
| Keywords | gene-therapydeafnesshearingfdamedicinebiotechhealthcaresciencemedical-breakthroughgeneticschildrenhealth-techtreatmentfda-approvalnytimesbiotechnologyrare-diseasemedical-researchpediatrics |
The layoffs affect about 8,000 employees, with Meta also planning to close 6,000 open roles, as the company focuses on artificial intelligence.
The maker of ChatGPT is taking a more open approach to cybersecurity than its chief rival, Anthropic.
| Keywords | openaiartificial-intelligenceaitechnologychatgptcybersecurityanthropictechsilicon-valleyllmsam-altmannew-modeltech-policyinnovationcomputing |
The new federal office will undo a change made after the 2010 Deepwater Horizon oil disaster. Critics say it could reduce environmental oversight.
The new deep-sea atlas underscores Beijing’s interest in ocean mining, its military ambitions and its claims to disputed waters.
In The Secret War Against Hate, Stephen J. Ross details the racist, anti-Semitic groups that sprang up in the latter half of the 20th century — and the spy network that worked to bring them to justice.
| Keywords | nazinazismspiesespionagewwiihistoryanti-semitismracismhate-groupsjusticestephen-j-rossterry-grossnprsecret-warextremismintelligencepost-wwiisocial-commentary |
A jury trial that is set to start on Monday could shift the course of the A.I. race, with Mr. Musk seeking billions of dollars in damages from Mr. Altman’s OpenAI.
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
| Keywords | trumpregenerondrug-priceshealthcaremedicine-costspharmaceuticalswhite-houseus-politicsaffordabilitymost-favored-nationpolicymedicationconsumer-protectionhealth-care-costsdrug-pricing |
The audit by the department’s inspector general follows months of lawmaker complaints over the congressionally mandated release of investigative files.